HR 1566
104th Congress
House
Taxation
Clinical trials
Commerce
Diseases
Drug industry
Health
Income tax
Orphan drugs
Pharmaceutical research
Science, Technology, Communications
Tax credits
To amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions and to provide for carryovers and carrybacks of unused credits.
Introduced: May 3, 1995
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 3, 1995
Referred to the House Committee on Ways and Means.
May 3, 1995
Sponsor introductory remarks on measure. (CR E939)
May 3, 1995
Introduced in House
Plain-English summary
Amends the Internal Revenue Code to extend permanently the tax credit for expenses of clinical testing of certain drugs for rare diseases or conditions. Allows a three-year carryback and 15-year carryforward of unused credit amounts, except that no credit may be carried to a taxable year beginning before January 1, 1995.
What's happening now
Referred to the House Committee on Ways and Means.
Committees of jurisdiction
1